AKRO
Akero Therapeutics Inc.
$46.41
+$1.19(+2.63%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$3.62B
Volume
864.72K
52W Range
$21.34 - $58.40
Target Price
$76.33
EPS Estimates Overview
| Current Quarter | $-0.94 | Next Quarter | $-0.97 |
| Current Year | $-3.74 | Next Year | $-4.12 |
| QoQ Growth | -3.2% | YoY Growth | -10.2% |
| 3Y EPS CAGR | N/A | Target Price | $76.33 |
| Consensus | Buy | Upside | +64.5% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKRO | $46.41 | +2.6% | 864.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |